Autoreactive HSP60 epitope-specific T-cells in early human atherosclerotic lesions
about
Mucosal tolerance to a combination of ApoB and HSP60 peptides controls plaque progression and stabilizes vulnerable plaque in Apob(tm2Sgy)Ldlr(tm1Her)/J miceTolerization against atherosclerosis using heat shock protein 60The Ratio of Regulatory (FOXP3+) to Total (CD3+) T Cells Determined by Epigenetic Cell Counting and Cardiovascular Disease Risk: A Prospective Case-cohort Study in Non-diabeticsVaccine against arteriosclerosis: an update.Elevated sodium leads to the increased expression of HSP60 and induces apoptosis in HUVECs.T cells in vascular inflammatory diseasesT-Cells Specific for a Self-Peptide of ApoB-100 Exacerbate Aortic Atheroma in Murine Atherosclerosis.Advances in immune-modulating therapies to treat atherosclerotic cardiovascular diseasesCan we vaccinate against atherosclerosis?Hsp60 chaperonopathies and chaperonotherapy: targets and agents.Readapting the adaptive immune response - therapeutic strategies for atherosclerosis.Intranasal immunization with heat shock protein 60 induces CD4(+) CD25(+) GARP(+) and type 1 regulatory T cells and inhibits early atherosclerosis.Identification of apoB-100 Peptide-Specific CD8+ T Cells in Atherosclerosis.Endothelial TNF-α induction by Hsp60 secreted from THP-1 monocytes exposed to hyperglycaemic conditions.The cathelicidin protein CRAMP is a potential atherosclerosis self-antigen in ApoE(-/-) mice.Immunohistochemistry of Human Hsp60 in Health and Disease: From Autoimmunity to Cancer.Oxidative Stress Induces HSP90 Upregulation on the Surface of Primary Human Endothelial Cells: Role of the Antioxidant 7,8-Dihydroxy-4-methylcoumarin in Preventing HSP90 Exposure to the Immune System.
P2860
Q27335174-9E397907-D7BC-4EBA-A0F3-2FF95F9B6B4CQ28081051-94BC03A0-B2E4-4E5D-BD5C-D0DA538DAC6CQ28277713-FA78564B-D405-4394-BCA3-F60E90545A2BQ33641227-E5919C7D-963E-4C7F-98EA-6118D045698AQ33788229-EC1A36C3-E46D-454F-AE11-4F56EFEE92E1Q34336323-28314D7A-40D6-4159-95D9-B569486B2627Q37660865-1C071630-6C86-4D3A-8930-D08A23A8D302Q37709623-49DD28B6-EA24-47B4-9E39-5925FBCAE185Q38137846-4075673E-FFFF-467A-9546-A3ACBBE7EFDFQ38167037-C8A45283-5989-4EDE-B55A-258FE08423F2Q38774904-F72674D7-473A-42E3-8173-1A776D2670DFQ40959589-6356DB21-260B-4256-82BE-C519D559D3D8Q41627194-5368FBB9-415D-4CF3-8B29-F44890758F48Q46262003-4BD6A239-8FD2-4013-9793-9A97C74CFDDFQ46485465-1EB6ED2B-BD6D-4997-8376-1ADD392EA23FQ49608238-1EAE93D9-38FF-47D1-A8CE-4382CA86240AQ54943937-09609C0B-D32D-4D21-BDD3-5A79D8D9C7E1
P2860
Autoreactive HSP60 epitope-specific T-cells in early human atherosclerotic lesions
description
2012 nî lūn-bûn
@nan
2012 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Autoreactive HSP60 epitope-specific T-cells in early human atherosclerotic lesions
@ast
Autoreactive HSP60 epitope-specific T-cells in early human atherosclerotic lesions
@en
Autoreactive HSP60 epitope-specific T-cells in early human atherosclerotic lesions
@nl
type
label
Autoreactive HSP60 epitope-specific T-cells in early human atherosclerotic lesions
@ast
Autoreactive HSP60 epitope-specific T-cells in early human atherosclerotic lesions
@en
Autoreactive HSP60 epitope-specific T-cells in early human atherosclerotic lesions
@nl
prefLabel
Autoreactive HSP60 epitope-specific T-cells in early human atherosclerotic lesions
@ast
Autoreactive HSP60 epitope-specific T-cells in early human atherosclerotic lesions
@en
Autoreactive HSP60 epitope-specific T-cells in early human atherosclerotic lesions
@nl
P2093
P2860
P3181
P1476
Autoreactive HSP60 epitope-specific T-cells in early human atherosclerotic lesions
@en
P2093
Barbara Rantner
Benno Cardini
Cecilia Grundtman
Elisabeth Onestingel
Georg Wick
Giovanni Almanzar
Julianna Leuenberger
Robert Öllinger
Ruurd van der Zee
Sarah Zehm
P2860
P304
P3181
P356
10.1016/J.JAUT.2012.07.006
P407
P577
2012-12-01T00:00:00Z